Albania
Tuberculosis profile
Population  2013 3.2 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.02 (0.014–0.027) 0.64 (0.45–0.86)
Mortality (HIV+TB only) 0 (–) 0 (–)
Prevalence  (includes HIV+TB) 0.85 (0.39–1.5) 27 (12–47)
Incidence  (includes HIV+TB) 0.59 (0.5–0.68) 18 (16–22)
Incidence (HIV+TB only)        
Case detection, all forms (%) 81 (69–95)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 0.58 (0.02–3.2) 0 (0–22)
MDR-TB cases among notified pulmonary
TB cases
2 (0–10) 0 (0–4)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 196   16
Pulmonary, clinically diagnosed 118   3
Extrapulmonary 141   0
       
Total new and relapse 474    
Previously treated, excluding relapses 0    
Total cases notified 474    
Among 474 new and relapse cases:
19 (4%) cases aged under 15 years; male:female ratio: 2.2
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 27 (14%) 4 (21%) 31
Laboratory-confirmed RR-/MDR-TB cases     2
Patients started on MDR-TB treatment     0
TB/HIV 2013 Number (%)
TB patients with known HIV status 109 (23)
HIV-positive TB patients 2 (2)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 2 (100)
HIV-positive TB patients on antiretroviral therapy (ART) 2 (100)
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate (%)
New and relapse cases registered in 2012 92
Previously treated cases, excluding relapse, registered in 2012 67
HIV-positive TB cases, all types, registered in 2012 86
RR-/MDR-TB cases started on second-line treatment in 2011  
XDR-TB cases started on second-line treatment in 2011  
Laboratories 2013  
Is second-line drug susceptibility testing available? No
Financing TB control 2014  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-05-29 Data: www.who.int/tb/data